Alpha emitters for targeted radionuclide therapy

• In: Diagnostics: A patient and pharmacist partnership in healthcare (SIG Nuclear/Radiologic Pharmacy) on Monday, 6 September 2004, 14:00-17:00
• At: New Orleans (USA) (2004)
• Type: Presentation
• By: ZALUTSKY, Michael (Duke University Medical Center, Radiology, Durham, NC, United States of America)
• Abstract:

  Radionuclide therapy (or targeted radiotherapy) is a promising strategy for cancer treatment because of the potential for delivering curative doses of radiation to tumor cells while leaving normal tissues intact. An important consideration in radionuclide therapy is matching the type of radiation that is emitted with the characteristics of the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login